Capecitabine and Appetite - increased - a phase IV clinical study of FDA data
Summary:
Appetite - increased is reported as a side effect among people who take Capecitabine (capecitabine), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Oxaliplatin, and have Colon cancer.
The phase IV clinical study analyzes which people have Appetite - increased when taking Capecitabine. It is created by eHealthMe based on reports of 59,451 people who have side effects when taking Capecitabine from the FDA, and is updated regularly.
What is Capecitabine?
Capecitabine has active ingredients of capecitabine. eHealthMe is studying from 59,495 Capecitabine users. Check the latest studies of Capecitabine.
What is Appetite - increased?
Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires) is found to be associated with 1,601 drugs and 2,026 conditions by eHealthMe. Check the latest studies of Appetite - increased.
59,451 people reported to have side effects when taking Capecitabine.
Among them, 29 people (0.05%) have Appetite - increased.

Among these 29 people:
How long have people been on Capecitabine when they have Appetite - increased? *
- < 1 month: 16.67 %
- 1 - 6 months: 83.33 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Appetite - increased when taking Capecitabine? *
- female: 57.69 %
- male: 42.31 %
What is the age of people who have Appetite - increased when taking Capecitabine? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 37.5 %
- 50-59: 6.25 %
- 60+: 56.25 %
What are other drugs people take besides Capecitabine? *
- Oxaliplatin: 6 people, 20.69%
- Dexamethasone: 5 people, 17.24%
- Ondansetron: 5 people, 17.24%
- Afinitor: 4 people, 13.79%
- Sandostatin: 4 people, 13.79%
- Lipitor: 3 people, 10.34%
- Aspirin: 2 people, 6.90%
- Betaxolol: 2 people, 6.90%
- Imodium Multi-Symptom Relief: 2 people, 6.90%
- Lonsurf: 2 people, 6.90%
What are other side effects people have besides Appetite - increased? *
- Fatigue (feeling of tiredness): 10 people, 34.48%
- Malaise (a feeling of general discomfort or uneasiness): 10 people, 34.48%
- Nausea (feeling of having an urge to vomit): 9 people, 31.03%
- Weight Increased: 7 people, 24.14%
- Cough: 7 people, 24.14%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 7 people, 24.14%
- Disease Progression: 7 people, 24.14%
- Diarrhea: 7 people, 24.14%
- Drug Ineffective: 6 people, 20.69%
- Taste - Impaired: 6 people, 20.69%
What are the existing conditions these people have? *
- Colon Cancer: 14 people, 48.28%
- Nausea (feeling of having an urge to vomit): 5 people, 17.24%
- Drug Hypersensitivity: 5 people, 17.24%
- Neuroendocrine Tumor: 4 people, 13.79%
- Stress And Anxiety: 1 person, 3.45%
- Pancreatic Carcinoma (pancreatic cancer): 1 person, 3.45%
- Neoplasm Malignant (cancer tumour): 1 person, 3.45%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 3.45%
- Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 3.45%
- Gastric Cancer Stage Ii (the tumour has penetrated the outer layer of the stomach. cancer cells have not spread to lymph nodes or other organs): 1 person, 3.45%
* Approximation only. Some reports may have incomplete information.
Do you take Capecitabine and have Appetite - increased?
- Check whether Appetite - increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Capecitabine:
- Capecitabine (59,495 reports)
Appetite - increased treatments and more:
- Appetite - increased (35,586 reports)
How severe was Appetite - increased and when was it recovered:
Expand to all the drugs that have ingredients of capecitabine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Capecitabine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Appetite - increased:
- Appetite - increased (1,601 drugs)
Browse all the conditions that are associated with Appetite - increased:
- Appetite - increased (2,026 conditions)
Related publications that referenced our studies
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
- Pinto HP, Bhat RM, Shet D, Dandekeri S, "Compound mucocutaneous adverse effects of oral capecitabine in a patient", Indian dermatology online journal, 2014 Jan .
- Kang SM, Baek JY, Hwangbo B, Kim HY, Lee GK, Lee HS, "A case of capecitabine-induced sarcoidosis", Tuberculosis and respiratory diseases, 2012 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on capecitabine (the active ingredients of Capecitabine) and Capecitabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Arginine and Norco - now
- Could Prozac cause Vocal Cord Disorder? - a second ago
- Could Riboflavin cause Gastrointestinal Disorder? - 2 seconds ago
- Could Anzemet cause Wound Infection? - 7 seconds ago
- Drug interactions of Nitroglycerin and Sodium Bicarbonate - 11 seconds ago
- Could Felodipine cause Abasia? - 12 seconds ago
- Could Synthroid cause Atelectasis? - 12 seconds ago
- Drug interactions of Doxazosin Mesylate and Ampyra - 19 seconds ago
- Could Lozol cause High Blood Cholesterol? - 26 seconds ago
- Drug interactions of Imodium and Synthroid - 28 seconds ago